Clinical Trial Update: Clinical Study of R744 to Peritoneal Dialysis Patients [Phase 3]

View source ↗

Summary

A phase 3 clinical study evaluating R744 in peritoneal dialysis patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• R744

Snippet

Sponsor: Chugai Pharmaceutical | Conditions: Peritoneal Dialysis Patients | Phase 3 | Status: COMPLETED